FIM
RGNX icon

Fernwood Investment Management’s Regenxbio RGNX Stock Holding History

Fernwood Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13,134
Closed -$259K – 143
2017
Q2 		$259K Sell
13,134
-1,720
-12% -$33.3K 0.19% 114
2017
Q1 		$287K Hold
14,854
– – 0.23% 105
2016
Q4 		$276K Sell
14,854
-23,746
-62% -$454K 0.26% 98
2016
Q3 		$541K Buy
+38,600
New +$426K 0.5% 60

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fernwood Investment Management's RGNX Position: Q3 2017 in Review

Fernwood Investment Management sold out of Regenxbio (RGNX) in Q3 2017, closing a stake of 13,134 shares — an estimated $259K sold.

Fernwood Investment Management first reported a position in RGNX in Q3 2016 and held it in 4 quarters. The position peaked at $541K in Q3 2016. 89 funds tracked by Wall St. Rank hold RGNX as of Q3 2017.

  • Fernwood Investment Management reported no remaining Regenxbio position as of Q3 2017 after selling out during the quarter.
  • Fernwood Investment Management sold 13,134 Regenxbio shares in Q3 2017, an estimated $259K.
  • Fernwood Investment Management first reported a position in Regenxbio in Q3 2016 and held it in 4 quarters.
  • Fernwood Investment Management's Regenxbio position peaked at $541K in Q3 2016.
  • 89 funds tracked by Wall St. Rank held Regenxbio as of Q3 2017.

Based on Fernwood Investment Management's 13F filing for Q3 2017, filed 9 Nov 2017.